Search results
Three drug-resistant infections in US tied to stem-cell injections in Mexico
Center for Infectious Disease Research and Policy· 23 hours agoThe first (patient B) was a man from Arizona who developed a right elbow osteoarticular infection...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Wealthcare Advisory Partners LLC
ETF DAILY NEWS· 7 hours agoWealthcare Advisory Partners LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities ...
MeadowBrook Investment Advisors LLC Takes Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 hours agoMeadowBrook Investment Advisors LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
The Huffington Post· 3 days agoThe reality TV star wore a custom Maison Margiela Artisanal gown by John Galliano with a metal...
Q3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by Analyst
ETF DAILY NEWS· 8 hours agoJohnson & Johnson (NYSE:JNJ – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson & Johnson in a research note issued on Tuesday ...
Spire Wealth Management Sells 5,652 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 8 hours agoSpire Wealth Management lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 13.6% during the fourth quarter, HoldingsChannel reports. The firm owned 35,894 shares of ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 7 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
WTNH-TV New Haven· 20 hours agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoKey Takeaways
Johnson & Johnson (NYSE:JNJ) Stake Increased by Sheets Smith Wealth Management
ETF DAILY NEWS· 11 hours agoSheets Smith Wealth Management raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 13,821 ...